Business

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

First Quarter Revenue Exceeded GuidanceFRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(15

articleDefinitive Healthcare Corp.May 8, 202514/company/definitive-healthcare-corp/news/definitive-healthcare-reports-financial-results-200500861
Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025

About this update from Definitive Healthcare Corp.

[{"type":"image","alt":"Definitive Healthcare Corp.","displaySize":"","headline":null,"caption":"Definitive Healthcare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YMii1YNRhhXnoJKWXGC71g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de","width":300,"height":61}},"lazy":false},{"type":"text","content":"First Quarter Revenue Exceeded Guidance","length":39,"tagName":"p"},{"type":"text","content":"FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.","length":266,"tagName":"p"},{"type":"text","content":"First Quarter 2025 Financial Highlights:","length":40,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024.","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) million, or (262)% of revenue, compared to $(12.7) million or (20)% of revenue in Q1 2024.","length":173,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted Net Income was $7.0 million, compared to $13.0 million in Q1 2024.","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA was $14.7 million, or 25% of revenue, compared to $20.0 million, or 32% of revenue in Q1 2024.","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash Flow from Operations was $26.1 million in the quarter.","length":59,"tagName":"p"}]},{"val":[{"type":"text","content":"Unlevered Free Cash Flow was $22.9 million in the quarter.","length":58,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":549,"olType":false},{"type":"text","content":"“We delivered first quarter results above the high end of our guidance for both revenue and earnings, reflecting solid new logo momentum across markets, and our continued focus on operational efficiency,” said Kevin Coop, CEO of Definitive Healthcare. “Even with rising macroeconomic u...

More updates from Definitive Healthcare Corp.

Definitive Healthcaregoodwill impairmentDefinitive Healthcare Corp.Net LossNet Income